Clinical applications of plasma neurofilament light in multiple sclerosis

Description

Join our upcoming webinar to explore the role plasma neurofilament light (NfL) biomarker could have in assessing multiple sclerosis (MS) disease activity and response to therapy. The growing evidence that elevated blood NfL levels can serve as a biomarker for disease activity and treatment response in MS is expected to catalyze the need for NfL testing in clinical laboratories.

In this webinar, the speakers, Drs. William Clarke and Elias Sotirchos, will focus on the clinical value and potential use of NfL in multiple sclerosis management and is meant to provide laboratory scientists with the latest insights and guidance regarding future use of NfL tests and potentially other blood biomarkers in multiple sclerosis. This webinar is essential for laboratory professionals aiming to stay at the forefront of MS diagnostics and enhance their laboratory's testing capabilities. Don't miss this opportunity to advance your understanding of this pivotal biomarker in multiple sclerosis.

Target audience

This activity is designed for physicians, lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), residents, and other laboratory professionals overseeing/conducting within this topic.

Learning objectives

At the end of this session, participants will be able to:

• Recognize the role of plasma neurofilament light (NfL) as a biomarker for disease activity and treatment response in multiple sclerosis.
• Apply best practices for implementing blood NfL testing in a laboratory setting.
• Summarize the current limitations for clinical adoption of NfL testing in multiple sclerosis management, and identify strategies to overcome existing challenges.

Faculty

William Clarke, PhD, MBA, DABCC
Professor of Pathology
Johns Hopkins University
Baltimore, MD

Elias Sotirchos, MD
Associate Professor
Johns Hopkins University
Baltimore, MD

Disclosures and Statement of Independence

The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.

The following faculty reported financial relationships:

• William Clarke, PhD, MBA, DABCC
  • Honorarium and/or Expenses: Roche Diagnostics, Werfen
  • Consulting Fees: Kinomica, Radiometer, HepQuant
  • Grant and/or Research Support: Roche Diagnostics, Radiometer, Red Abbey Labs, Truvian, Thermo Fisher Scientific
  • Committee, Board, and/or Advisory Board Memberships: Werfen, Saladax Biomedical, Truvian, Red Abbey Labs
  • Stocks and/or Bonds: Truvian, Red Abbey Labs, Saladax Biomedical

• Elias Sotirchos, MD
  • Grant and/or Research Support: Alexion, Roche/Genentech, UCB, Ad Scientiam, Astoria Biologica, National Multiple Sclerosis Society (NMSS), National Institutes of Health (NIH), Patient Centered Outcomes Research Institute (PCORI)
  • Committee, Board, and/or Advisory Board Memberships: Alexion, Amgen, TG Therapeutics, Roche/Genentech

Content validity

All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR all scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.

Accreditation statement

This activity is approved for 1.0 ACCENT® continuing education credits. Activity ID #4397. This activity was planned in accordance with ACCENT® Standards and Policies.

Successful completion statement

Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email [email protected].